loader2
Login Open ICICI 3-in-1 Account

Clean Science & Technology Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Clean Science & Technology Ltd. 30 Jan 2025 18:36 PM

Q3FY25 Quarterly Result Announced for Clean Science & Technology Ltd.

Specialty Chemicals company Clean Science & Technology announced Q3FY25 results

  • Total Revenue for Q3FY25 stood at Rs 240.8 crore, registering a 23% YoY growth from Rs 194.7 crore in Q3FY24.
  • EBITDA increased 14% YoY to Rs 98.5 crore in Q3FY25, compared to Rs 86.6 crore in Q3FY24, with EBITDA margin at 41.5% (down from 45.0% in Q3FY24).
  • Profit Before Tax (PBT) rose to Rs 85.3 crore in Q3FY25, a 3% YoY increase from Rs 83.1 crore in Q3FY24, with PBT margin at 35.9% (down from 43.2% in Q3FY24).
  • Profit After Tax (PAT) for Q3FY25 was Rs 65.6 crore, up 5% YoY from Rs 62.7 crore in Q3FY24, with PAT margin at 27.6% (down from 32.6% in Q3FY24).

Result PDF

Specialty Chemicals firm Clean Science and Technology declares Q3FY22 result:

  • Mixed quarter:
    • Recorded highest ever revenue and PAT in Q3 FY2022 . Total revenues increased by 18% and 44% on QoQ and YoY basis respectively
    • Despite end product price hike, gross margins impacted as raw material price increase was steeper during Q3. Other key factors impacting margins are coal prices and moderation in product mix with pharma segment share significantly higher in Q3 compared to Q2
  • Focus on sustainability
    • Company has been awarded the “Greenco Silver” rating by GreenCo - Green Company Rating System. Clean Science and Technology Limited is the first specialty chemical company in the country to be given the “Greenco” certification
    • This rating is a clear validation of our company’s emphasis on clean, green and sustainable practices and processes
  • Product launch and capex
    • Commissioned plants for manufacturing PBQ (Para benzoquinone), BHA and TBHQ. PBQ is an import substitute with Clean Science being the only company in India to manufacture PBQ
    • Cash capex of ~INR 110 crore cumulatively during 9M FY2022, all funded from internal accruals
  • Performance chemicals - Increased realizations across all products. Strong volume offtake for BHA during Q3 FY22 compared to Q3 FY21
  • Pharma chemicals – Increased volume offtake across products, improved realizations for DCC during Q3 FY22 compared to Q3 FY21
  • FMCG chemicals – Increased volume offtake and improved realizations for all key products in Q3 FY22 compared to Q3 FY21

 

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Play Store App Store
market app